Paul Jensen
Optometrist · Renton, WANPI 1891792370
Payments from drug & device makers
What this record shows
Biotissue Holdings Inc. accounts for 75.8% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $2,282 and has fallen 96.5% since, to $81 in 2025. Among optometrist clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $115.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$2K
- Oyster Point Pharma, Inc.$172
- Bausch & Lomb, A Division Of Bausch Health US, LLC$131
- Mallinckrodt Enterprises LLC$125
- Johnson & Johnson Surgical Vision, Inc.$108
- Tarsus Pharmaceuticals, Inc.$100
- plus $91 from 4 others
Across 4 payments — averaging $4926.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$20K
What the payments were for
- Travel & lodging$1,47349%
- Food & beverage$1,52651%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 15 | $2,272 |
| Oyster Point Pharma, Inc. | 2 | $172 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $131 |
| Mallinckrodt Enterprises LLC | 1 | $125 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $108 |
| Tarsus Pharmaceuticals, Inc. | 1 | $100 |
| Lombart Brothers, Inc. | 1 | $40 |
| LKC Technologies, Inc. | 1 | $25 |
| Bausch & Lomb Americas Inc. | 1 | $14 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TYRVAYA$149
- ACTHAR$125
- BIOTRUE ONE DAY$113
- TearScience Lipiflow System$108
- XDEMVY$100
How this compares
$2,999 in reported general payments places this provider in the 90th percentile of 1,267 optometrist providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Timolol Maleate | 14 | $627 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 16 | $619 |
| Dorzolamide Hcl | 19 | $471 |
| Latanoprost | 39 | $443 |
| Prednisolone Acetate | 14 | $381 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 22 | $282 |
| ErythromycinErythromycin Base | 14 | $135 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Renton
- Andy LaiRenton$8K
- Traci LeeRenton$6K
- David KadingKirkland$397K
- Peter BergenskeOtis Orchards$355K
- Casey ClaypoolSpokane Valley$323K
- Charles ClaytonBellevue$195K
- Herminder BoparaiBellevue$131K
- Rajiv PatelVancouver$118K
- Alan ChousTacoma$115K
- Roya HabibiSeattle$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.